HealthcareMarkets International (HMi) is the only publication to focus exclusively on bringing you global news, M&A, financial results, investor views, investment cases, executive moves, interviews and in-depth articles covering industry trends, policy and regulation and technology innovation in healthcare. Edited by Nick Herbert, HMi draws upon unique data and high-quality journalism to deliver in-depth analysis of the sector’s stories, alongside contributions from key industry associations and sector experts. Contributors include PwC, International Finance Corporation, Asian Development Bank, Bain & Company, LEK Consulting, McDermott Will & Emery and Colliers International. HMi also incorporates the International Medical Travel Journal, the world leading journal for the medical travel sector.

HealthcareMarkets International is an authorised news source for Google news

Digital subscriptions are available offering 10 editions per year, plus full access to the online news archive at hmi.LaingBuissonNews.com

HMi is published by LaingBuisson, along with two sister titles, HealthcareMarkets UK and CareMarkets UK which have been supporting clients to understand their markets, make informed decisions and deliver better outcomes by providing market intelligence for over 30 years.

About LaingBuisson

LaingBuisson has been serving clients for over 30 years with insights, analysis and data on market structures, policy and strategy across healthcare, social care and education. Today it is a leading business intelligence provider built around its data capabilities. Many years of survey data, often with valuable time series, insights from consulting projects, long term relationships with providers, governments and regulators and accumulated experience have created a unique repository of knowledge. LaingBuisson is the chosen provider of independent sector healthcare market data to the UK Government’s Office for National Statistics. 

InFocus: Penny Sherlock and Adam Scott of Mansfield Advisors examine opportunities for pharmaceuticals in women’s health. InLaw: David Dowling of Ropes & Gray looks ahead to likely trends in European life sciences and healthcare. InConversation: Dr Felix Dahm, CEO of Dayton Therapeutics, discusses plans to combine oncologist know-how, AI and data mining to identify high-yield candidates for cancer indications. InSight: Building healthcare distribution platforms. Nick Herbert talks to Paul Tomasic, head of European Healthcare, Houlihan Lokey.